HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases. - Brun MK; Bjørlykke KH; Viken MK; Stenvik GE; Klaasen RA; Gehin JE; Warren DJ; Sexton J; Sandanger Ø; Kvien TK; Mørk C; Haavardsholm EA; et al. (Journal of internal medicine, 2023)